Nifty

:

25682.75

Sensex

:

83277.15

211.65 (0.83%)
650.39 (0.79%)

Login

Nifty
Sensex

:
:

25682.75
83277.15

211.65 (0.83%)
650.39 (0.79%)

Syngene International Ltd.

Pharmaceuticals & Drugs - Global

Rating :

41/99

BSE: 539268 | NSE: SYNGENE

Watchlist

NSE BSE

435.05

16-Feb-2026

Open
High
Low
Previous Close

437.05
446
432.8
434.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

853243
374223307.65
760
426.5

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,527.86
49.73
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,072.26
0.29%
3.69

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.79
10.77
4.49

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.20
9.79
2.24

PAT CAGR (%)

10 Years
5 Years
3 Years

6.87
4.15
2.23

P:E (Median)

8 Years
5 Years
3 Years

55.85
57.74
57.09

P:BV (Average)

8 Years
5 Years
3 Years

7.21
7.28
6.94

EV:EBITDA (Average)

8 Years
5 Years
3 Years

26.14
27.70
26.67

Earnings Forecasts:

(Updated: 14-02-2026)

Description 2024 2025 2026 2027
Adj EPS 12.35 8.44 11.43 15.84
P/E Ratio 35.23 51.55 38.06 27.47
Revenue 3642.4 3681.13 4197.84 4898.28
EBITDA 1043.7 875.41 1073.43 1351.59
Net Income 496.2 326.04 460.56 638.27
ROA 7.66 5.49 7.67 9.39
P/B Ratio 3.70 3.50 3.23 2.92
ROE 11.05 7.01 8.76 10.96
FCFF 443.8 169.95 272.3 412.59
FCFF Yield 2.53 0.97 1.55 2.36
Net Debt -819.6 -965.08 -1206.15 -2078.47
BVPS 117.43 124.18 134.59 149.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 834.40 877.10 -4.87% 830.10 821.30 1.07% 799.30 726.50 10.02% 948.40 864.70 9.68%
Expenses 649.70 627.40 3.55% 652.60 612.70 6.51% 631.20 578.30 9.15% 638.40 565.40 12.91%
EBITDA 184.70 249.70 -26.03% 177.50 208.60 -14.91% 168.10 148.20 13.43% 310.00 299.30 3.58%
EBIDTM 22.14% 28.47% 21.38% 25.40% 21.03% 20.40% 32.69% 34.61%
Other Income 14.50 19.10 -24.08% 14.20 16.40 -13.41% 16.60 17.70 -6.21% 18.40 15.30 20.26%
Interest 6.20 6.70 -7.46% 7.40 7.00 5.71% 5.90 7.40 -20.27% 10.10 8.50 18.82%
Depreciation 97.10 92.30 5.20% 100.10 93.70 6.83% 94.60 91.70 3.16% 89.60 95.70 -6.37%
PBT 30.10 169.80 -82.27% 84.20 124.30 -32.26% 84.20 98.80 -14.78% 228.70 210.40 8.70%
Tax 13.60 46.70 -70.88% 18.00 27.70 -35.02% 10.20 24.90 -59.04% 54.30 20.60 163.59%
PAT 16.50 123.10 -86.60% 66.20 96.60 -31.47% 74.00 73.90 0.14% 174.40 189.80 -8.11%
PATM 1.98% 14.03% 7.97% 11.76% 9.26% 10.17% 18.39% 21.95%
EPS 0.41 3.06 -86.60% 1.64 2.40 -31.67% 1.84 1.83 0.55% 4.33 4.71 -8.07%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 917.10 943.70 -2.82% 910.60 891.00 2.20% 874.50 789.70 10.74% 1,018.00 916.90 11.03%
Expenses 707.90 661.80 6.97% 711.10 650.50 9.32% 668.10 619.90 7.78% 674.40 600.00 12.40%
EBITDA 209.20 281.90 -25.79% 199.50 240.50 -17.05% 206.40 169.80 21.55% 343.60 316.90 8.43%
EBIDTM 22.81% 29.87% 21.91% 26.99% 23.60% 21.50% 33.75% 34.56%
Other Income 15.40 20.00 -23.00% 15.40 20.80 -25.96% 17.70 18.10 -2.21% 18.90 16.10 17.39%
Interest 11.90 12.40 -4.03% 13.20 13.10 0.76% 11.60 11.70 -0.85% 15.90 12.90 23.26%
Depreciation 113.70 108.70 4.60% 116.50 110.90 5.05% 111.20 106.90 4.02% 106.10 111.10 -4.50%
PBT 28.40 180.80 -84.29% 85.20 137.30 -37.95% 101.30 101.30 0.00% 240.50 209.00 15.07%
Tax 13.40 49.70 -73.04% 18.10 31.20 -41.99% 14.60 25.60 -42.97% 57.20 20.40 180.39%
PAT 15.00 131.10 -88.56% 67.10 106.10 -36.76% 86.70 75.70 14.53% 183.30 188.60 -2.81%
PATM 1.64% 13.89% 7.37% 11.91% 9.91% 9.59% 18.01% 20.57%
EPS 0.37 3.26 -88.65% 1.67 2.64 -36.74% 2.15 1.88 14.36% 4.55 4.69 -2.99%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 3,412.20 3,373.30 3,203.10 3,193.50 2,601.40 2,179.40 2,011.90 1,825.60 1,423.10 1,200.90 1,107.00 Net Sales Growth 3.73% 5.31% 0.30% 22.76% 19.36% 8.33% 10.20% 28.28% 18.50% 8.48% Cost Of Goods Sold 839.50 17.10 56.60 -42.00 -21.60 526.50 519.40 531.30 381.70 321.80 310.40 Gross Profit 2,572.70 3,356.20 3,146.50 3,235.50 2,623.00 1,652.90 1,492.50 1,294.30 1,041.40 879.10 796.60 GP Margin 75.40% 99.49% 98.23% 101.32% 100.83% 75.84% 74.18% 70.90% 73.18% 73.20% 71.96% Total Expenditure 2,571.90 2,455.80 2,324.40 2,260.90 1,863.60 1,528.10 1,409.70 1,291.10 1,033.00 816.20 726.60 Power & Fuel Cost - 55.00 54.20 69.20 64.40 57.40 45.80 41.30 34.70 30.40 30.80 % Of Sales - 1.63% 1.69% 2.17% 2.48% 2.63% 2.28% 2.26% 2.44% 2.53% 2.78% Employee Cost - 841.70 761.20 812.20 697.80 641.50 572.20 465.40 376.90 308.60 249.30 % Of Sales - 24.95% 23.76% 25.43% 26.82% 29.43% 28.44% 25.49% 26.48% 25.70% 22.52% Manufacturing Exp. - 1,106.10 1,031.20 1,078.80 913.70 130.00 103.70 85.70 66.70 55.50 29.50 % Of Sales - 32.79% 32.19% 33.78% 35.12% 5.96% 5.15% 4.69% 4.69% 4.62% 2.66% General & Admin Exp. - 373.00 314.80 250.40 168.70 136.10 140.60 146.00 142.40 83.40 64.80 % Of Sales - 11.06% 9.83% 7.84% 6.48% 6.24% 6.99% 8.00% 10.01% 6.94% 5.85% Selling & Distn. Exp. - 19.40 16.20 18.00 11.80 6.10 11.10 7.70 6.10 6.30 4.80 % Of Sales - 0.58% 0.51% 0.56% 0.45% 0.28% 0.55% 0.42% 0.43% 0.52% 0.43% Miscellaneous Exp. - 43.50 90.20 74.30 28.80 30.50 16.90 13.70 24.50 10.20 4.80 % Of Sales - 1.29% 2.82% 2.33% 1.11% 1.40% 0.84% 0.75% 1.72% 0.85% 3.34% EBITDA 840.30 917.50 878.70 932.60 737.80 651.30 602.20 534.50 390.10 384.70 380.40 EBITDA Margin 24.63% 27.20% 27.43% 29.20% 28.36% 29.88% 29.93% 29.28% 27.41% 32.03% 34.36% Other Income 63.70 70.50 88.00 72.60 108.40 83.30 96.10 76.20 136.10 93.60 6.30 Interest 29.60 31.20 29.50 45.20 24.10 27.70 34.60 32.30 22.70 17.50 8.40 Depreciation 381.40 367.20 368.80 359.10 309.70 274.50 219.30 164.20 131.40 114.30 97.30 PBT 427.20 589.60 568.40 600.90 512.40 432.40 444.40 414.20 372.10 346.50 281.00 Tax 96.10 153.60 90.80 127.90 87.90 63.70 104.20 83.50 67.00 59.20 40.20 Tax Rate 22.50% 24.71% 16.29% 21.28% 18.25% 13.63% 20.21% 20.16% 18.01% 17.09% 14.31% PAT 331.10 468.00 466.50 473.00 393.80 403.70 411.50 330.70 305.10 287.30 240.80 PAT before Minority Interest 331.10 468.00 466.50 473.00 393.80 403.70 411.50 330.70 305.10 287.30 240.80 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.70% 13.87% 14.56% 14.81% 15.14% 18.52% 20.45% 18.11% 21.44% 23.92% 21.75% PAT Growth -31.51% 0.32% -1.37% 20.11% -2.45% -1.90% 24.43% 8.39% 6.20% 19.31% EPS 8.22 11.62 11.58 11.74 9.77 10.02 10.21 8.21 7.57 7.13 5.98

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 3,720.20 3,642.40 3,488.60 3,192.90 2,604.20 2,184.30 2,011.90 1,825.60 1,423.10 Net Sales Growth 5.05% 4.41% 9.26% 22.61% 19.22% 8.57% 10.20% 28.28% Cost Of Goods Sold 920.50 17.00 56.70 -42.00 -21.60 526.50 519.40 531.30 381.70 Gross Profit 2,799.70 3,625.40 3,431.90 3,234.90 2,625.80 1,657.80 1,492.50 1,294.30 1,041.40 GP Margin 75.26% 99.53% 98.37% 101.32% 100.83% 75.90% 74.18% 70.90% 73.18% Total Expenditure 2,761.50 2,600.60 2,474.20 2,260.20 1,863.70 1,531.20 1,408.50 1,289.90 1,032.60 Power & Fuel Cost - 69.00 69.70 69.20 64.80 57.40 45.80 41.30 34.70 % Of Sales - 1.89% 2.00% 2.17% 2.49% 2.63% 2.28% 2.26% 2.44% Employee Cost - 983.90 888.70 841.70 718.10 660.20 580.40 472.70 379.60 % Of Sales - 27.01% 25.47% 26.36% 27.57% 30.22% 28.85% 25.89% 26.67% Manufacturing Exp. - 1,184.30 1,082.00 1,078.80 913.70 130.10 103.70 85.70 66.70 % Of Sales - 32.51% 31.02% 33.79% 35.09% 5.96% 5.15% 4.69% 4.69% General & Admin Exp. - 278.00 264.10 219.90 148.50 120.50 131.60 137.40 139.30 % Of Sales - 7.63% 7.57% 6.89% 5.70% 5.52% 6.54% 7.53% 9.79% Selling & Distn. Exp. - 22.70 20.30 18.50 11.70 6.40 11.10 7.70 6.10 % Of Sales - 0.62% 0.58% 0.58% 0.45% 0.29% 0.55% 0.42% 0.43% Miscellaneous Exp. - 45.70 92.70 74.10 28.50 30.10 16.50 13.80 24.50 % Of Sales - 1.25% 2.66% 2.32% 1.09% 1.38% 0.82% 0.76% 1.72% EBITDA 958.70 1,041.80 1,014.40 932.70 740.50 653.10 603.40 535.70 390.50 EBITDA Margin 25.77% 28.60% 29.08% 29.21% 28.43% 29.90% 29.99% 29.34% 27.44% Other Income 67.40 71.80 90.60 72.60 108.40 83.30 96.10 76.20 136.10 Interest 52.60 53.10 47.20 45.20 24.10 27.70 34.60 32.30 22.70 Depreciation 447.50 432.60 425.90 366.50 309.70 274.50 219.30 164.20 131.40 PBT 455.40 627.90 631.90 593.60 515.10 434.20 445.60 415.40 372.50 Tax 103.30 163.70 110.80 129.20 88.60 64.30 104.80 83.80 67.10 Tax Rate 22.68% 24.81% 17.85% 21.77% 18.29% 13.70% 20.27% 20.17% 18.01% PAT 352.10 496.20 510.00 464.40 395.80 404.90 412.10 331.60 305.40 PAT before Minority Interest 352.10 496.20 510.00 464.40 395.80 404.90 412.10 331.60 305.40 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.46% 13.62% 14.62% 14.54% 15.20% 18.54% 20.48% 18.16% 21.46% PAT Growth -29.79% -2.71% 9.82% 17.33% -2.25% -1.75% 24.28% 8.58% EPS 8.74 12.32 12.66 11.53 9.82 10.05 10.23 8.23 7.58

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 4,638.90 4,191.50 3,618.90 3,292.00 2,818.30 2,174.10 1,967.20 1,720.10 1,413.10 1,024.70 Share Capital 402.50 402.00 401.40 400.80 400.00 400.00 200.00 200.00 200.00 200.00 Total Reserves 4,208.60 3,772.10 3,154.70 2,804.20 2,341.40 1,735.20 1,739.20 1,491.90 1,187.90 805.80 Non-Current Liabilities 409.50 494.00 780.40 972.20 840.10 325.20 515.00 612.60 697.70 725.10 Secured Loans 0.00 100.00 489.00 531.50 512.40 0.00 346.60 568.80 689.80 725.20 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16.70 0.00 0.00 Long Term Provisions 40.40 38.10 41.70 34.40 52.00 40.90 37.40 29.00 19.90 18.10 Current Liabilities 1,328.60 1,098.60 1,157.20 1,231.50 1,130.40 1,540.00 1,128.60 783.30 600.30 534.00 Trade Payables 346.50 254.00 260.40 235.30 239.10 222.80 223.50 203.40 102.50 74.40 Other Current Liabilities 809.10 688.90 749.70 655.90 571.60 955.10 677.60 475.60 379.40 276.40 Short Term Borrowings 102.50 41.70 86.30 258.10 259.90 308.90 190.70 78.10 97.20 165.80 Short Term Provisions 70.50 114.00 60.80 82.20 59.80 53.20 36.80 26.20 21.20 17.40 Total Liabilities 6,377.00 5,784.10 5,556.50 5,495.70 4,788.80 4,039.30 3,610.80 3,116.00 2,711.10 2,283.80 Net Block 2,206.90 2,276.80 2,211.80 2,354.30 2,163.40 1,983.70 1,336.80 1,030.40 810.40 580.20 Gross Block 4,483.40 4,293.50 3,993.60 3,882.50 3,404.40 2,967.40 2,121.20 1,660.70 1,331.90 1,111.40 Accumulated Depreciation 2,276.50 2,016.70 1,781.80 1,528.20 1,241.00 983.70 784.40 630.30 521.50 531.20 Non Current Assets 4,343.10 3,932.30 2,884.10 3,292.10 2,987.80 2,427.90 1,848.20 1,396.70 1,187.00 949.10 Capital Work in Progress 880.10 759.60 126.20 346.40 237.20 234.10 273.70 155.40 174.90 236.80 Non Current Investment 870.10 435.00 116.40 270.60 316.60 74.30 40.30 0.30 0.00 0.00 Long Term Loans & Adv. 173.10 230.30 164.50 150.70 115.10 107.80 121.90 94.90 91.20 71.70 Other Non Current Assets 178.60 189.50 217.10 131.60 155.50 28.00 75.50 115.70 110.50 60.40 Current Assets 2,033.90 1,851.80 2,355.30 2,203.60 1,801.00 1,611.40 1,762.60 1,719.30 1,524.10 1,334.70 Current Investments 597.90 492.60 824.40 763.80 423.30 738.40 716.00 157.70 540.40 276.60 Inventories 150.30 234.00 332.80 179.40 59.60 25.20 43.40 86.00 32.20 37.70 Sundry Debtors 469.40 427.50 484.40 508.20 474.40 398.20 338.70 266.80 198.70 185.20 Cash & Bank 652.50 528.20 509.30 515.10 638.20 280.30 435.40 966.50 527.30 719.90 Other Current Assets 163.80 111.30 140.10 157.00 205.50 169.30 229.10 242.30 225.50 115.30 Short Term Loans & Adv. 45.80 58.20 64.30 80.10 31.60 68.70 3.90 5.90 23.90 25.10 Net Current Assets 705.30 753.20 1,198.10 972.10 670.60 71.40 634.00 936.00 923.80 800.70 Total Assets 6,377.00 5,784.10 5,239.40 5,495.70 4,788.80 4,039.30 3,610.80 3,116.00 2,711.10 2,283.80

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 4,726.70 4,257.60 3,618.00 3,297.60 2,821.40 2,175.80 1,968.40 1,720.40 Share Capital 402.50 402.00 401.40 400.80 400.00 400.00 200.00 200.00 Total Reserves 4,244.90 3,786.60 3,151.20 2,809.30 2,344.40 1,736.90 1,740.40 1,492.20 Non-Current Liabilities 643.40 708.90 955.20 971.70 839.70 325.20 515.00 612.60 Secured Loans 0.00 100.00 489.00 531.50 512.40 0.00 346.60 568.80 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16.70 Long Term Provisions 43.30 40.70 43.70 34.40 52.00 40.90 37.40 29.00 Current Liabilities 1,396.40 1,144.30 1,188.20 1,228.90 1,133.00 1,539.20 1,128.60 783.60 Trade Payables 352.00 255.50 258.00 232.80 241.60 222.00 223.50 203.50 Other Current Liabilities 845.10 726.80 778.20 655.80 571.60 955.10 677.60 475.70 Short Term Borrowings 119.60 41.70 86.30 258.10 259.90 308.90 190.70 78.10 Short Term Provisions 79.70 120.30 65.70 82.20 59.90 53.20 36.80 26.30 Total Liabilities 6,766.50 6,110.80 5,761.40 5,498.20 4,794.10 4,040.20 3,612.00 3,116.60 Net Block 2,767.40 2,808.90 2,618.80 2,354.30 2,163.40 1,983.70 1,336.80 1,030.40 Gross Block 5,229.30 4,945.80 4,481.40 3,882.50 3,404.40 2,967.40 2,121.20 1,660.70 Accumulated Depreciation 2,461.90 2,136.90 1,862.60 1,528.20 1,241.00 983.70 784.40 630.30 Non Current Assets 4,479.20 4,151.90 3,336.10 3,292.30 2,987.40 2,427.60 1,847.90 1,396.40 Capital Work in Progress 1,266.10 838.10 176.90 346.40 237.20 234.10 273.70 155.40 Non Current Investment 36.20 34.70 94.10 270.30 316.30 74.00 40.00 0.00 Long Term Loans & Adv. 196.40 239.60 181.10 151.20 115.00 107.80 121.90 94.90 Other Non Current Assets 178.80 189.50 217.10 131.60 155.50 28.00 75.50 115.70 Current Assets 2,287.30 1,958.90 2,425.30 2,205.90 1,806.70 1,612.60 1,764.10 1,720.20 Current Investments 610.50 513.20 824.40 763.80 423.30 738.40 716.00 157.70 Inventories 155.50 238.50 332.80 179.40 59.60 25.20 43.40 86.00 Sundry Debtors 526.80 441.50 529.30 507.70 475.70 398.20 338.70 266.80 Cash & Bank 786.90 563.50 531.70 517.90 642.60 281.50 436.90 967.40 Other Current Assets 207.60 106.40 132.40 157.00 205.50 169.30 229.10 242.30 Short Term Loans & Adv. 104.20 95.80 74.70 80.10 31.60 68.70 3.90 5.90 Net Current Assets 890.90 814.60 1,237.10 977.00 673.70 73.40 635.50 936.60 Total Assets 6,766.50 6,110.80 5,761.40 5,498.20 4,794.10 4,040.20 3,612.00 3,116.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,113.80 913.40 838.40 582.20 698.00 677.40 629.80 445.60 398.10 308.10 PBT 621.60 557.30 600.90 481.70 467.40 515.70 330.70 305.10 287.30 240.80 Adjustment 366.10 286.30 375.30 381.30 278.60 223.20 212.50 248.10 148.40 132.90 Changes in Working Capital 227.60 168.20 -4.10 -176.60 34.80 44.90 182.30 -26.80 36.90 -25.50 Cash after chg. in Working capital 1,215.30 1,011.80 972.10 686.40 780.80 783.80 725.50 526.40 472.60 348.20 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -101.50 -98.40 -133.70 -104.20 -82.80 -106.40 -95.70 -80.80 -74.50 -40.10 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -810.40 -383.50 -688.20 -611.50 -628.10 -428.40 -646.50 -349.60 -469.10 -751.20 Net Fixed Assets -310.40 -933.30 109.10 -587.30 -440.10 -806.60 -578.80 -309.30 -158.60 -305.10 Net Investments -540.40 13.20 93.60 -294.50 72.80 -56.40 -598.30 382.40 -263.80 -130.60 Others 40.40 536.60 -890.90 270.30 -260.80 434.60 530.60 -422.70 -46.70 -315.50 Cash from Financing Activity -136.50 -536.30 -340.20 -31.30 58.00 -225.50 -72.40 -78.70 -81.20 716.10 Net Cash Inflow / Outflow 166.90 -6.40 -190.00 -60.60 127.90 23.50 -89.10 17.30 -152.20 273.00 Opening Cash & Equivalents 66.60 72.10 259.00 318.90 191.80 163.70 251.80 234.50 387.30 115.70 Closing Cash & Equivalent 233.50 66.60 72.10 259.00 318.90 191.80 163.70 251.80 234.50 387.30

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 1,167.60 1,042.10 823.50 580.60 701.20 677.10 630.40 446.20 PBT 659.80 620.80 593.60 484.40 469.30 516.90 331.60 305.40 Adjustment 470.90 390.40 384.90 381.70 278.80 223.20 212.80 248.20 Changes in Working Capital 152.10 156.00 -18.20 -179.70 36.70 44.10 182.10 -26.60 Cash after chg. in Working capital 1,282.80 1,167.20 960.30 686.40 784.80 784.20 726.50 527.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -115.20 -125.10 -136.80 -105.80 -83.60 -107.10 -96.10 -80.80 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -744.70 -495.60 -656.40 -611.50 -628.10 -428.40 -646.50 -349.30 Net Fixed Assets -310.40 -933.30 109.10 -587.30 -440.10 -806.60 -578.80 Net Investments -540.40 13.20 93.60 -294.50 72.80 -56.40 -598.30 Others 106.10 424.50 -859.10 270.30 -260.80 434.60 530.60 Cash from Financing Activity -141.80 -551.40 -342.50 -31.30 58.00 -225.50 -72.40 -78.70 Net Cash Inflow / Outflow 281.10 -4.90 -175.40 -62.20 131.10 23.20 -88.50 18.20 Opening Cash & Equivalents 85.70 89.50 261.80 323.30 193.00 165.20 252.70 234.50 Closing Cash & Equivalent 367.10 85.70 89.50 261.80 323.30 193.00 165.20 252.70

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 114.56 103.83 88.59 79.97 68.53 53.38 48.48 42.30 34.70 25.14 ROA 7.70% 8.08% 8.40% 7.66% 9.15% 10.76% 9.83% 10.47% 11.50% 13.00% ROE 10.65% 12.07% 13.99% 13.24% 16.56% 20.20% 18.21% 19.81% 24.00% 26.19% ROCE 14.39% 13.76% 15.61% 13.19% 15.35% 19.57% 16.94% 16.70% 17.60% 19.85% Fixed Asset Turnover 0.77 0.77 0.81 0.71 0.68 0.79 0.97 0.95 0.98 1.08 Receivable days 48.33 51.89 56.66 68.93 73.07 66.84 60.53 59.70 58.34 60.19 Inventory Days 20.71 32.26 29.24 16.77 7.10 6.22 12.94 15.16 10.62 12.55 Payable days 6408.85 1658.62 -2153.93 -4008.24 160.11 54.64 59.61 54.99 38.31 36.00 Cash Conversion Cycle -6339.81 -1574.47 2239.83 4093.94 -79.94 18.42 13.85 19.87 30.65 36.74 Total Debt/Equity 0.02 0.03 0.16 0.25 0.28 0.32 0.41 0.47 0.58 0.89 Interest Cover 20.92 19.89 14.29 20.99 17.87 15.90 13.82 17.39 20.80 34.45

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 115.46 104.19 88.51 80.09 68.61 53.42 48.51 42.30 ROA 7.71% 8.59% 8.25% 7.69% 9.17% 10.77% 9.86% 9.80% ROE 11.23% 13.18% 13.73% 13.29% 16.59% 20.21% 18.26% 18.05% ROCE 15.42% 15.55% 15.43% 13.24% 15.40% 19.60% 16.98% 15.76% Fixed Asset Turnover 0.72 0.74 0.76 0.71 0.69 0.79 0.97 0.86 Receivable days 48.33 50.73 59.21 68.92 73.02 66.84 60.53 68.43 Inventory Days 19.66 29.85 29.24 16.75 7.09 6.22 12.94 22.06 Payable days 6521.69 1652.80 -2132.64 -4008.24 160.70 54.25 59.30 72.96 Cash Conversion Cycle -6453.70 -1572.22 2221.09 4093.91 -80.60 18.82 14.17 17.52 Total Debt/Equity 0.03 0.03 0.16 0.25 0.28 0.32 0.41 0.47 Interest Cover 13.43 14.15 14.13 21.10 17.94 15.94 13.86 17.41

Top Investors:

icici prudential elss tax saver fund

dsp arbitrage fund

nippon life india trustee ltd-a/c nippon india pha

mirae asset arbitrage fund

government of singapore

government pension fund global

lici new endowment plus-growth fund

uti-flexi cap fund

franklin india flexi cap fund

Annual Reports:

News Update:

Syngene Internation. - Quarterly Results
23rd Jan 2026, 00:00 AM

Read More
Syngene International extends long-standing strategic collaboration with Bristol Myers Squibb
19th Jan 2026, 10:51 AM

The collaboration between Syngene and Bristol Myers Squibb began in 1998, culminating in the establishment of the Biocon Bristol Myers Squibb Research and Development Center
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback